Scott G. Davis - 05 Nov 2025 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Signature
/s/ Jerome Wong
Issuer symbol
EKSO
Transactions as of
05 Nov 2025
Transactions value $
$0
Form type
4
Filing time
07 Nov 2025, 17:48:41 UTC
Previous filing
18 Mar 2025
Next filing
12 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Davis Scott G. CEO, Director 101 GLACIER POINT, SUITE A, SAN RAFAEL /s/ Jerome Wong 07 Nov 2025 0001908860

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Award $0 +80K +362.12% $0.00 102K 05 Nov 2025 Direct F1, F2, F3
holding EKSO Common Stock 373 05 Nov 2025 By 401(k) F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.
F2 The RSU grant was approved by the Board of Directors in a meeting held on November 5, 2025, under the Company's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). Each RSU Award was fully vested at grant.
F3 On June 2, 2025, the Issuer effected a 1-for-15 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.